EVIDENCE LIBRARY

Why Did Formulation and Timing Matter in a Neuroleptic Malignant Syndrome Case?

A medication error and a later adverse reaction can belong to the same history while occurring under different exposure conditions. A 2018 case report traced several antipsychotic events before neuroleptic malignant syndrome developed.

Separate events in the record

The patient first entered care after an intentional overdose involving two medications. Weeks later, an administration error substituted short-acting zuclopenthixol acetate for the intended depot preparation. Confusion followed that error, but the report described no accompanying fever, rigidity, or raised creatine kinase characteristic of the later syndrome.

What preceded the later illness?

Zuclopenthixol was paused for two months and subsequently restarted orally. Around two weeks after restarting it, dehydration and biochemical abnormalities were documented. Two days later, fever, marked rigidity, altered consciousness, and increased creatine kinase prompted a diagnosis of neuroleptic malignant syndrome.

How to evaluate a proposed cause

The authors discussed dehydration, organ dysfunction, and concurrent treatment as possible contributors. These were mechanistic interpretations of a complex case. The report did not directly demonstrate which factor triggered the syndrome or quantify its individual contribution. For a reader reviewing a medication-related hospitalization, the formulation, route, pause, restart, titration, laboratory sequence, and symptom onset should remain visible. Grouping all events under a single overdose label loses information needed to assess temporal plausibility. This case supports careful reconstruction of successive exposures and competing contributors to the later illness.

Source

Read the full scientific paper. DOI 10.1136/bcr-2017-223922.